Conservative management of endometrial cancer: a survey amongst European clinicians
- 62 Downloads
To investigate differences and similarities in the clinical approach of young clinicians managing women with endometrial cancer (EC) conservatively.
A web-based survey was carried out. A platform of the European Network of Young Gynaecological Oncologists (ENYGO) database was used. A 38-item multiple-choice questionnaire was used to evaluate current practice in fertility-sparing management of EC. The survey covered investigations, treatment options, follow-up and management of recurrence and future family planning. Descriptive statistics were used.
Overall, 116 out of 650 (17.84%) ENYGO members responded to the survey. In 92 (79.3%) centres, the caseload of early stage EC treated conservatively was less than 10 per year. One hundred and seven responders (93.8%) believe that treatment with progestins could be offered in grade 1 EC without myometrial invasion, but a minority would recommend it even for grade 2 tumours with no myometrial invasion or grade 1 with superficial invasion. The diagnostic tool for establishing grade of tumour was hysteroscopy with dilatation and curettage in 64 (55%) centres. Medroxyprogesterone acetate represents the most commonly prescribed progestogen (55, 47.4%). In 78 (67.2%) centres, a repeat endometrial biopsy was offered after 3 months of treatment commencement. Recurrences are treated mostly with hysterectomy (81, 69.9%) with only a small number of responders recommending to repeat progestin treatment. Lynch syndrome is a contraindication for conservative management in half of the responders (57, 49.1%). Most clinicians agree that patients should be referred promptly for assisted reproductive techniques once complete response has been achieved (68, 58.6%).
Our study shows that conservative management is increasingly offered to women affected by early stage EC wishing to preserve their fertility. Further studies and joint registries are required to evaluate safety and effectiveness of this approach in this probably growing number of patients.
KeywordsEndometrial cancer Conservative management Progestins Assisted reproduction Pregnancies
MR: manuscript writing, protocol development, and data analysis. IZ: manuscript editing, protocol development, and data analysis. MJH: manuscript editing, protocol development, and data analysis. KZ: manuscript editing and data analysis. RL: manuscript editing and data collection. PD: manuscript editing and data collection. DL: manuscript editing and data collection. VS: manuscript editing and data collection. SP: manuscript editing and data collection. IB: manuscript writing/editing, protocol development, and data analysis
The study was funded by Charles University research project Progress Q-28 Oncology (MJH).
Compliance with ethical standards
Conflict of interest
Signed disclosure is added in a separate file, and there is no conflict of interest.
Informed consent is not needed, as it is an original research based on a questionnaire.
- 1.Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/#Twenty. Accessed Jan 14 2014
- 3.Surveillance, Epidemiology and End Result programme. https://seer.cancer.gov/statfacts/html/corp.html. Accesed Apr 2 2017
- 5.World Cancer Research Fund/American Institute for Cancer Research (2013). Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Endometrial Cancer. https://www.wcrf.org/int/continuous-update-project
- 9.Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/#Twenty. Accessed Jan 14 2014
- 10.National Cancer Institute. Endometrial cancer treatment Physician Data Query (PDQ).2015;http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/healthprofessional. Accessed 1 Apr 2015
- 17.Ushijima K, Yahata H, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrialGoogle Scholar